Chimera Investment (CIMO) Cash & Equivalents (2009 - 2026)

Chimera Investment has disclosed Cash & Equivalents across 17 years of filings, most recently posting $476.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $476.2 million, up 87.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $476.2 million (up 87.97% YoY), and the FY2025 annual result was $278.6 million, up 231.65% from the prior year.
• Cash & Equivalents came in at $476.2 million for Q1 2026 at Chimera Investment, up from $278.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $491.5 million in Q3 2025 to a low of $84.0 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $200.9 million (2023), against an average of $219.5 million.
• Across the five-year window, Cash & Equivalents slumped 73.75% in 2022 and surged 404.98% in 2025, its largest moves.
• Chimera Investment's Cash & Equivalents stood at $264.6 million in 2022, then dropped by 16.22% to $221.7 million in 2023, then slumped by 62.11% to $84.0 million in 2024, then soared by 231.65% to $278.6 million in 2025, then soared by 70.94% to $476.2 million in 2026.
• The last three Cash & Equivalents figures came in at $476.2 million (Q1 2026), $278.6 million (Q4 2025), and $491.5 million (Q3 2025), per Business Quant data.